{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:39:46Z","timestamp":1788565186779,"version":"build-2803163510"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.dld.2006.02.010","type":"journal-article","created":{"date-parts":[[2006,4,5]],"date-time":"2006-04-05T14:46:00Z","timestamp":1144248360000},"page":"404-408","source":"Crossref","is-referenced-by-count":27,"title":["Doxorubicin coupled to lactosaminated albumin: Effects on rats with liver fibrosis and cirrhosis"],"prefix":"10.1016","volume":"38","author":[{"given":"G.","family":"Di Stefano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Fiume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Domenicali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Busi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Chieco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Kratz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mattioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pariali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2006.02.010_bib1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1600-0676.1993.tb00611.x","article-title":"Distribution of asialoglycoprotein receptor in human hepatocellular carcinoma","volume":"13","author":"Hyodo","year":"1993","journal-title":"Liver"},{"key":"10.1016\/j.dld.2006.02.010_bib2","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/sj.bjc.6690708","article-title":"The asialoglycoprotein receptor in human hepatocellular carcinomas: its expression on proliferating cells","volume":"81","author":"Trer\u00e8","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.dld.2006.02.010_bib3","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S1590-8658(03)00212-3","article-title":"Doxorubicin coupled to lactosaminated human albumin remains confined within mouse liver cells after the intracellular release from the carrier","volume":"35","author":"Di Stefano","year":"2003","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2006.02.010_bib4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1478-3231.2004.0916.x","article-title":"Liver targeted doxorubicin: effects on regerating rat hepatocytes","volume":"24","author":"Di Stefano","year":"2004","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2006.02.010_bib5","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jhep.2005.02.045","article-title":"Doxorubicin coupled to lactosaminated albumin inhibits the growth of hepatocellular carcinomas induced in rats by diethylnitrosamine","volume":"43","author":"Fiume","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2006.02.010_bib6","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/S0021-9258(17)38039-0","article-title":"Effect of reductive lactosamination on the hepatic uptake of bovine ribonuclease A dimer","volume":"253","author":"Wilson","year":"1978","journal-title":"J Biol Chem"},{"key":"10.1016\/j.dld.2006.02.010_bib7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0014-5793(81)80179-2","article-title":"Hepatocyte targeting of adenine-9-\u03b2-d-arabinofuranoside 5\u2032-monophosphate (ara-AMP) coupled to lactosaminated albumin","volume":"129","author":"Fiume","year":"1981","journal-title":"FEBS Lett"},{"key":"10.1016\/j.dld.2006.02.010_bib8","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/0006-2952(86)90084-5","article-title":"Drug targeting in antiviral chemotherapy. A chemically stable conjugate of 9-\u03b2-d-arabinofuranosyl adenine 5\u2032-monophosphate with lactosaminated albumin accomplishes a selective delivery of the drug to liver cells","volume":"35","author":"Fiume","year":"1986","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.dld.2006.02.010_bib9","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/hep.1840180122","article-title":"Coupling of the antiviral drug ara-AMP to lactosaminated albumin leeds to a specific uptake in rat and human hepatocytes","volume":"18","author":"Jansen","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2006.02.010_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0140-6736(88)92946-7","article-title":"Inhibition Hepatitis B virus replication by vidarabine monophosphate conjugated with lactosaminated serum albumin","volume":"2","author":"Fiume","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2006.02.010_bib11","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/hep.510230401","article-title":"Adenine arabinoside monophosphate coupled to lactosaminated albumin, administered for 4 weeks to patients with chronic type B hepatitis, decreased viremia without producing significant side effects","volume":"23","author":"Torrani Cerenzia","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2006.02.010_bib12","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0168-8278(01)00018-6","article-title":"Efficacy and safety of L-HSA-ara-AMP in chronic hepatitis B patients non responder to interferon therapy: a randomized clinical trial","volume":"34","author":"Zarski","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2006.02.010_bib13","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.dld.2005.11.006","article-title":"Doxorubicin coupled to lactosaminated albumin: enhanced drug levels in rat hepatocarcinomas","volume":"38","author":"Di Stefano","year":"2006","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2006.02.010_bib14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ejps.2004.09.005","article-title":"A novel method for coupling doxorubicin to lactosaminated human albumin by an acid sensitive hydrazone bond: synthesis, characterization and preliminary biological properties of the conjugate","volume":"23","author":"Di Stefano","year":"2004","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.dld.2006.02.010_bib15","series-title":"Ascites and renal dysfunction in the liver disease. Pathogenesis, diagnosis and treatment","first-page":"379","article-title":"Renal dysfunction and ascites in carbon tetrachloride-induced cirrhosis in rats","author":"Cl\u00e0ria","year":"1999"},{"key":"10.1016\/j.dld.2006.02.010_bib16","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0378-4347(00)86151-4","article-title":"Analysis of adriamycin and adriamycinol in micro volumes of rat plasma","volume":"272","author":"Bots","year":"1983","journal-title":"J Chromatogr"},{"key":"10.1016\/j.dld.2006.02.010_bib17","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/hep.1840190629","article-title":"Classification of chronic hepatitis: diagnosis, grading and staging","volume":"19","author":"Desmet","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2006.02.010_bib18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/hep.1840030118","article-title":"Is cirrhosis of the liver experimentally produced by CCl4 an adequate model of human cirrhois?","volume":"3","author":"Tamayo","year":"1983","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2006.02.010_bib19","first-page":"713","article-title":"Anthracyclines: a review of general and special toxicity studies","volume":"7","author":"Mazu\u00e8","year":"1995","journal-title":"Int J Oncol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865806000648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865806000648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T10:15:00Z","timestamp":1627208100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865806000648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S1590865806000648"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2006.02.010","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}